Ontology highlight
ABSTRACT: From the clinical editor
In this study, porphyrin-DNA nanocomplexes were investigated as anti-cancer therapeutics inducing ROS production in a light-dependent manner. Efficacy is demonstrated in vitro as well as a in a bladder cancer xenograft model.
SUBMITTER: Ghosh S
PROVIDER: S-EPMC3946208 | biostudies-literature | 2014 Feb
REPOSITORIES: biostudies-literature
Ghosh Supratim S Ucer Kamil B KB D'Agostino Ralph R Grant Ken K Sirintrapun Joseph J Thomas Michael J MJ Hantgan Roy R Bharadwaj Manish M Gmeiner William H WH
Nanomedicine : nanotechnology, biology, and medicine 20130827 2
DNA and porphyrin based therapeutics are important for anti-cancer treatment. The present studies demonstrate single-stranded DNA (ssDNA) assembles with meso-tetra-4-pyridyl porphine (MTP) forming porphyrin:DNA nano-complexes (PDN) that are stable in aqueous solution under physiologically relevant conditions and undergo dissociation with DNA release in hydrophobic environments, including cell membranes. PDN formation is DNA-dependent with the ratio of porphyrin:DNA being approximately two DNA nu ...[more]